Landos Biopharma, Inc.

1800 Kraft Drive
Suite 216
Blacksburg
Virginia
24060
United States

Email: info@landosbiopharma.com

Show jobs for this employer

About Landos Biopharma, Inc.

Landos Biopharma is an emerging biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases. Landos’ lead clinical asset, BT-11, is a novel, locally-acting small molecule targeting inflammatory bowel disease (IBD) that is expected to enter clinical testing for Crohn’s disease in 2018. Landos also has a robust pipeline of compounds for other autoimmune diseases. Landos is headquartered in Blacksburg, VA.
YEAR FOUNDED:
2016
LEADERSHIP:
President and CEO: Josep Bassaganya-Riera, DVM, PhD
CSO: Raquel Hontecillas, DVM, PhD
Operations, Marketing and Communications Manager: Lee Sandstead
Scientific Director: Dr. Andrew Leber
Senior Business Advisor: Chris Garabedian
TECHNOLOGY
Please click here for Landos Biopharma's technology.

41 articles with Landos Biopharma, Inc.